BIOLIFE4D is committed to perfecting the technology to make viable organ replacement a safe, accessible and affordable reality. With BIOLIFE4D, a patient-specific, fully functioning heart will be created through 3D bioprinting and the patient’s own cells, eliminating the challenges of organ rejection and long donor waiting lists that plague existing organ transplant methods.
BIOLIFE4D plans to offer their stock for investment soon. Until then, you can indicate your interest in investing. By checking the box below you can become one of the very first to know when BIOLIFE4D stock is available for you to make an investment.
Watch our video below.